EXHIBIT ASchedule 13g Agreement • February 3rd, 2005 • Ziff Asset Management Lp • Services-prepackaged software
The undersigned, Ziff Asset Management, L.P., a Delaware limited partnership, PBK Holdings, Inc., a Delaware corporation, and Philip B. Korsant, hereby agree and acknowledge that the information required by this Schedule 13G, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any further amendments or supplements thereto shall also be filed on behalf of each of them.
AGREEMENTSchedule 13g Agreement • February 15th, 2022 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Perceptive Advisors LLC • Biological products, (no disgnostic substances)
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 16th, 2021 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 14th, 2024 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 13th, 2003 • Boston Partners Asset Management L P • Investment advice
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Inamed Corporation.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Perceptive Advisors LLC • Laboratory analytical instruments
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • December 17th, 2021 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Ordinary Shares of Autolus Therapeutics plc.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 14th, 2022 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 16th, 2021 • Perceptive Advisors LLC • In vitro & in vivo diagnostic substances
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 14th, 2024 • Perceptive Advisors LLC • Biological products, (no disgnostic substances)
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 16th, 2021 • Perceptive Advisors LLC • Biological products, (no disgnostic substances)
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 16th, 2021 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Perceptive Advisors LLC • Blank checks
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 16th, 2021 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Perceptive Advisors LLC • Biological products, (no disgnostic substances)
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 15th, 2022 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 16th, 2021 • Perceptive Advisors LLC • Blank checks
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • July 19th, 2022 • Perceptive Advisors LLC • Biological products, (no disgnostic substances)
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • February 9th, 2024 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Adverum Biotechnologies, Inc.
AGREEMENTSchedule 13g Agreement • February 4th, 2015 • Summit Partners L P • Computer communications equipment
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of A10 Networks, Inc.
AGREEMENTSchedule 13g Agreement • March 2nd, 2009 • Mendon Capital Advisors Corp • Services-management services
Each of the undersigned, pursuant to Rule 13d-1(k)(l) under the Securities Exchange Act of 1934, as amended, hereby agrees that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of the shares of Common Stock of CRM Holdings, Ltd., and that the amended Schedule 13G to which this Agreement is appended as Exhibit 1 is to be filed with the Securities and Exchange Commission on behalf of each of the undersigned on or about the date hereof.
AGREEMENTSchedule 13g Agreement • June 10th, 2014 • Baker Bros. Advisors Lp • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Avanir Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13g Agreement • February 14th, 2005 • Mendon Capital Advisors Corp • Savings institutions, not federally chartered
Each of the undersigned, pursuant to Rule 13d-1(k)(l) under the Securities Exchange Act of 1934, as amended, hereby agrees that only one statement containing the information required by Schedule 13G needs be filed with respect to the ownership by each of the undersigned of the shares of common stock of Bridge Street Financial Inc., and that the Schedule 13G to which this Agreement is appended as Exhibit 1 is to be filed with the Securities and Exchange Commission on behalf of each of the undersigned on or about the date hereof.
AGREEMENTSchedule 13g Agreement • February 14th, 2022 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
Agreement of Advent Venture Partners LLP, Advent Private Equity Fund III Affiliates, Advent Management III Limited Partnership, Advent Private Equity Fund III A LTD Partnership, Advent Private Equity Fund III B LTD Partnership, Advent Private Equity...Schedule 13g Agreement • February 17th, 2009 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Each of the undersigned hereby agree that the Schedule 13G to which this Agreement is attached as Exhibit 1 is filed on behalf of it pursuant to Rule 13d-1(k)(1) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Notwithstanding the foregoing, each of the undersigned disclaim beneficial ownership of the shares of the other, except to the extent of his or its pecuniary interest therein.
AGREEMENTSchedule 13g Agreement • April 10th, 2014 • Baker Bros. Advisors Lp • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Aquinox Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13g Agreement • February 14th, 2020 • Perceptive Advisors LLC • Pharmaceutical preparations
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • March 1st, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Cogent Biosciences, Inc.
AGREEMENTSchedule 13g Agreement • February 10th, 2015 • Sierra Ventures IX, L.P. • Semiconductors & related devices
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of the shares of Common Stock of InvenSense, Inc.
AGREEMENTSchedule 13g Agreement • February 16th, 2021 • Perceptive Advisors LLC • Biological products, (no disgnostic substances)
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
AGREEMENTSchedule 13g Agreement • May 14th, 2002 • Howe Robert W • Services-computer processing & data preparation
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need to be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Atlantic Data Services, Inc.
AGREEMENTSchedule 13g Agreement • February 5th, 2021 • Baker Bros. Advisors Lp • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Shares of Zymeworks Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13g Agreement • February 14th, 2020 • Perceptive Advisors LLC • Biological products, (no disgnostic substances)
The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
